Abstract
With the increase in the incidence of food allergies and recent adrenaline auto-injector (AAI) shortage in the UK, it is important that schools remain updated about the policy on the emergency use of AAI in schools for children at risk of anaphylaxis. The purpose of this audit is to review current practice in schools in a UK region covered by the Paediatric Allergy Service at the East and North Hertfordshire NHS Trust. We were then able to identify whether schools are aware of and following the national Department of Health guidance regarding emergency AAI use, including provision of spare pens. An online questionnaire was developed to gather information on the schools’ respective policies regarding emergency AAI use, and their awareness and engagement with the recent “Spare Pens” policy. This was sent to all 230 schools within the districts of East and North Hertfordshire, Stevenage and Welwyn Hatfield, covering 78,450 students. Out of 230 schools, 180 completed the questionnaire, covering 62,695 children aged 3-18 years. Of this cohort, 814 children are diagnosed to be at risk of anaphylaxis and prescribed with AAIs. 649 (79.7%) have allergy action plans in school. 179 (99.4%) schools train their staff regarding management of anaphylaxis, with 138 (77.1%) training every year or less. Although 136 (75.6%) were aware of the Spare Pen policy, only 32 (17.8%) stock their own AAIs. 164 (91.1%) schools keep children’s own AAIs on site, (159/164) 97% of which have them within 5 minutes’ reach, and (118/164) 72.0% store them appropriately. Majority of the respondent schools are compliant with current guidance and are aware of the “Spare pen” policy. However, there remains a need to ensure that children at risk of anaphylaxis are provided with their own action plans and AAIs that are readily accessible, because only a minority of school’s stock spare pens.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.